(Q48617366)

13 February 2018

title

A double blind randomized pilot trial of naloxone in the treatment of acute ischemic stroke (English)

1 reference

22 November 2022

1 reference

22 November 2022

author name string

F. Federico

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1783533

22 November 2022

V. Lucivero

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1783533

22 November 2022

P. Lamberti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1783533

22 November 2022

A. Fiore

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1783533

22 November 2022

C. Conte

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1783533

22 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1783533

22 November 2022

publication date

1 December 1991

1 reference

13 February 2018

full work available at URL

http://link.springer.com/content/pdf/10.1007/BF02336951.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF02336951/fulltext.html

22 November 2022

1 reference

http://link.springer.com/content/pdf/10.1007/BF02336951

22 November 2022

1 reference

Italian journal of neurological sciences

22 November 2022

published in

1 reference

13 February 2018

volume

12

1 reference

13 February 2018

issue

6

1 reference

13 February 2018

page(s)

557-563

1 reference

13 February 2018

A dose-escalation study of large doses of naloxone for treatment of patients with acute cerebral ischemia

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02336951

Spontaneous improvement after acute ischemic stroke. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02336951

High-dose naloxone infusions in normals. Dose-dependent behavioral, hormonal, and physiological responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02336951

Failure of naloxone to reverse vascular neurologic deficits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02336951

Intravenously and iontophoretically administered naloxone reverses ischemic changes in rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02336951

Diagnosis of reversible versus irreversible cerebral ischemia by the intravenous administration of naloxone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02336951

Treatment of experimental stroke: comparison of naloxone and thyrotropin releasing hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02336951

Neuropeptides and central nervous system injury. Clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02336951

High-dose intravenous naloxone for the treatment of acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02336951

Kappa-opioid receptor changes and neurophysiological alterations during cerebral ischemia in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02336951

The effects of naloxone on cerebral blood flow and cerebral function during relative cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02336951

Effects of enkephalins, morphine, and naloxone on pial arteries during perivascular microapplication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02336951

A phase I trial of naloxone treatment in acute spinal cord injury

21 January 2018

1 reference

12 December 2020

A double blind trial of naloxone in the treatment of acute stroke

1 reference

12 December 2020

Effect of β-Endorphin on Calcium Uptake in the Brain

1 reference

12 December 2020

Improvement in injury induced hypocalcia by high-dose naloxone intervention

1 reference

12 December 2020

Reversal of Induced Ischemic Neurologic Deficit in Gerbils by the Opiate Antagonist Naloxone

1 reference

12 December 2020

Naloxone administration to patients with acute stroke

1 reference

12 December 2020

Treatment of experimental stroke with opiate antagonists. Effects on neurological function, infarct size, and survival

1 reference

12 December 2020

Naloxone therapy during focal cerebral ischemia evaluation in a primate model

1 reference

12 December 2020

Lipid antioxidant properties of naloxone in vitro

1 reference

12 December 2020

Naloxone effect on the neurological deficit induced by forebrain ischemia in rats

1 reference

12 December 2020

Morphine antagonises prostaglandin E1- mediated inhibition of human platelet aggregation

1 reference

12 December 2020

The Canadian Neurological Scale: validation and reliability assessment

1 reference

12 December 2020

CSF beta-endorphin and leu-enkephalin levels in the acute and chronic stages of cerebral infarction

1 reference

12 December 2020

Naloxone reversal of neurologic deficit

1 reference

12 December 2020

FUNCTIONAL EVALUATION: THE BARTHEL INDEX

1 reference

12 December 2020

[Our experience with naloxone in standard neurosurgical practice]

1 reference

12 December 2020

CSF and plasma levels of pro-opiomelanocortin-related peptides in reversible ischaemic attacks and strokes.

1 reference

12 December 2020

Increase of β-endorphin levels in cerebrospinal fluid but not in plasma in patients with cerebral infarction

1 reference

12 December 2020

Opiate antagonists in the treatment of stroke

1 reference

12 December 2020

Naloxone in cerebral ischemia: preliminary data

1 reference

12 December 2020

High concentrations of naloxone attenuate N-methyl-D-aspartate receptor-mediated neurotoxicity

1 reference

12 December 2020

Protective actions of naloxone in hemorrhagic shock

1 reference

12 December 2020

Effects of (D-Met2,Pro5)-enkephalinamide and naloxone on pial vessels in cats

1 reference

12 December 2020

Naloxone ameliorates the pathophysiologic changes which lead to and attend an acute stroke in stroke-prone/SHR

1 reference

12 December 2020

Naloxone in stroke: worth a trial?

1 reference

12 December 2020

Double-blind placebo-controlled trial of naloxone on motor deficits in acute cerebrovascular disease

1 reference

12 December 2020

NALOXONE REVERSAL OF ISCHAEMIC NEUROLOGICAL DEFICITS IN MAN

1 reference

12 December 2020

Maryland State Medical Journal

28

14

61

F.I. Mahoney

1965

1 reference

22 November 2022

Identifiers

DOI

10.1007/BF02336951

1 reference

13 February 2018

1 reference

13 February 2018